Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody​
RSV studies identify risk factors in older adults, household transmission routes​
Study shows nirsevimab provides significant protection against RSV​
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants​
Reports describe good maternal RSV vaccine, drug uptake in their first season​
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness​
RSV vaccine prompts robust immune response in older recipients over 2 seasons​
US flu activity climbs, with more deaths in kids​
VA study shows COVID more severe than RSV, flu​
US flu markers show more rises as COVID levels decline​
Only 6 symptoms, conditions appear unique to long COVID, suggesting overlap with other post-viral infections​
RSV tied to high complication, death rates in hospitalized older adults​
Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California​
CDC data suggest flu is on the way out​
RSV vaccination coverage remains low among older US adults​
CDC reports 14 more pediatric flu deaths, 115 total​
FDA approves use of RSV vaccine in at-risk younger adults​
CDC reports 11 more pediatric flu deaths​
Medical societies recommend RSV vaccines for older or immune-compromised adults​
Up to 56,000 people died from COVID-19 or RSV last year​